Tower Research Capital »

Veradermics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Veradermics (MANE) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Veradermics

Tip: Access up to 7 years of quarterly data

All positions including Veradermics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Veradermics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $632 10 63.20

More positions owned by Tower Research Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shares Etf Trust Daily Semiconduc (SOXL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Inc Cap Stk Cl A (GOOGL)
Ishares Tr Core Us Aggbd Et (AGG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vaneck Etf Trust Pharmaceutcl Etf (PPH)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)

View all positions for Tower Research Capital

Top funds holding Veradermics

Suvretta Capital Management
Sr One Capital Management
Citadel Advisors
FMR
Viking Global Investors
Siren
Adage Capital Partners GP
Standard Life Aberdeen
Infinitum Asset Management
Vanguard Capital Management
Marshall Wace
Balyasny Asset Management
Paradigm Biocapital Advisors
Ameriprise Financial
Woodline Partners

View all funds holding Veradermics